SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The June 2023 quarter revenue stood at Rs. 3523.10 millions, up 6.74% as compared to Rs. 3300.70 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2023 is Rs. -198.80 millions as compared to Net Loss of Rs. -191.80 millions of corresponding quarter ended June 2022Operating profit surged to 212.10 millions from the corresponding previous quarter of 161.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 3523.10 3300.70 6.74 3523.10 3300.70 6.74 14438.10 12683.40 13.83
Other Income 20.70 64.80 -68.06 20.70 64.80 -68.06 221.40 187.60 18.02
PBIDT 212.10 161.60 31.25 212.10 161.60 31.25 1561.80 991.10 57.58
Interest 255.10 225.00 13.38 255.10 225.00 13.38 900.60 752.70 19.65
PBDT -43.00 -63.40 -32.18 -43.00 -63.40 -32.18 661.20 203.50 224.91
Depreciation 258.30 280.50 -7.91 258.30 280.50 -7.91 1109.00 1120.10 -0.99
PBT -301.30 -343.90 -12.39 -301.30 -343.90 -12.39 -447.80 -916.60 -51.15
TAX -102.50 -152.10 -32.61 -102.50 -152.10 -32.61 -225.70 -331.00 -31.81
Deferred Tax -102.50 -152.10 -32.61 -102.50 -152.10 -32.61 -224.60 -331.00 -32.15
PAT -198.80 -191.80 3.65 -198.80 -191.80 3.65 -222.10 -585.60 -62.07
Equity 360.00 360.00 0.00 360.00 360.00 0.00 360.00 360.00 0.00
PBIDTM(%) 6.02 4.90 22.97 6.02 4.90 22.97 10.82 7.81 38.43

Solara Active Pharma Share Price

489.30 -4.40 (-0.89%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×